Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron

Author： Pavesi M.  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 866-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is EQ-5D a valid measure of HRQoL in patients with movement disorders?: A comparison with SF-36 and FIM questionnaires

By Ghislandi S.   Apolone G.   Garattini L.   Ghislandi I.  

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 125-130

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Mirabegron in Overactive Bladder: A Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 93, Iss. 3, 2014-08 ,pp. : 326-337

Karger

Access to resources Recommend Favorite

Combination of solifenacin and mirabegron for overactive bladder management

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 498-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urodynamic Efficacy and Safety of Mirabegron Add‐on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 171-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acupuncture versus Solifenacin for Treatment of Overactive Bladder and Its Correlation with Urine Nerve Growth Factor Levels: A Randomized, Placebo-Controlled Clinical Trial

By  

Urologia Internationalis, Vol. 93, Iss. 4, 2014-07 ,pp. : 437-443

Karger

Access to resources Recommend Favorite